Segui
Anna Tesei
Anna Tesei
IRST IRCCS
Email verificata su irst.emr.it
Titolo
Citata da
Citata da
Anno
3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained.
TA Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, Bevilacqua A
Scientific Reports, 2016
10662016
Modeling neoplastic disease with spheroids and organoids
M Zanoni, M Cortesi, A Zamagni, C Arienti, S Pignatta, A Tesei
Journal of hematology & oncology 13, 1-15, 2020
1862020
Cell counting and viability assessment of 2D and 3D cell cultures: expected reliability of the trypan blue assay
F Piccinini, A Tesei, C Arienti, A Bevilacqua
Biological procedures online 19, 1-12, 2017
1262017
Epidermal growth factor receptor family and its role in gastric cancer
C Arienti, S Pignatta, A Tesei
Frontiers in oncology 9, 1308, 2019
1182019
In vitro preclinical models for a rational design of chemotherapy combinations in human tumors
W Zoli, L Ricotti, A Tesei, F Barzanti, D Amadori
Critical reviews in oncology/hematology 37 (1), 69-82, 2001
1142001
p16INK4A and CDH13 hypermethylation in tumor and serum of non‐small cell lung cancer patients
P Ulivi, W Zoli, D Calistri, F Fabbri, A Tesei, M Rosetti, M Mengozzi, ...
Journal of cellular physiology 206 (3), 611-615, 2006
962006
Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell cultures
D Giustarini, F Galvagni, A Tesei, A Farolfi, M Zanoni, S Pignatta, ...
Free Radical Biology and Medicine 89, 972-981, 2015
942015
Role of RAF/MEK/ERK pathway, p‐STAT‐3 and Mcl‐1 in sorafenib activity in human pancreatic cancer cell lines
P Ulivi, C Arienti, D Amadori, F Fabbri, S Carloni, A Tesei, I Vannini, ...
Journal of cellular physiology 220 (1), 214-221, 2009
942009
Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines
W Zoli, P Ulivi, A Tesei, F Fabbri, M Rosetti, R Maltoni, DC Giunchi, ...
Breast Cancer Research 7, 1-9, 2005
932005
The role of mesenchymal stem cells in radiation-induced lung fibrosis
M Zanoni, M Cortesi, A Zamagni, A Tesei
International journal of molecular sciences 20 (16), 3876, 2019
912019
Anticancer drug discovery using multicellular tumor spheroid models
M Zanoni, S Pignatta, C Arienti, M Bonafè, A Tesei
Expert opinion on drug discovery 14 (3), 289-301, 2019
902019
Mitotic catastrophe and apoptosis induced by docetaxel in hormone‐refractory prostate cancer cells
F Fabbri, D Amadori, S Carloni, G Brigliadori, A Tesei, P Ulivi, M Rosetti, ...
Journal of cellular physiology 217 (2), 494-501, 2008
792008
Concerns, challenges and promises of high-content analysis of 3D cellular models
N Carragher, F Piccinini, A Tesei, OJT Jr, M Bickle, P Horvath
Nature reviews Drug discovery 17 (8), 606-606, 2018
762018
Sigma receptors as endoplasmic reticulum stress “gatekeepers” and their modulators as emerging new weapons in the fight against cancer
A Tesei, M Cortesi, A Zamagni, C Arienti, S Pignatta, M Zanoni, M Paolillo, ...
Frontiers in pharmacology 9, 711, 2018
692018
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells
L Gibellini, M Pinti, F Boraldi, V Giorgio, P Bernardi, R Bartolomeo, M Nasi, ...
The FASEB Journal 28 (12), 5122-5135, 2014
692014
Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer
W Zoli, L Ricotti, M Dal Susino, F Barzanti, GL Frassineti, S Folli, A Tesei, ...
British journal of cancer 81 (4), 609-615, 1999
691999
Cancer multicellular spheroids: volume assessment from a single 2D projection
F Piccinini, A Tesei, C Arienti, A Bevilacqua
Computer methods and programs in biomedicine 118 (2), 95-106, 2015
672015
Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts
C Leonetti, M Scarsella, G Zupi, W Zoli, D Amadori, L Medri, F Fabbri, ...
Molecular cancer therapeutics 5 (4), 919-926, 2006
592006
In Vitro Schedule-dependent Interaction between Docetaxel and Gemcitabine in Human Gastric Cancer Cell Lines
L Ricotti, A Tesei, F De Paola, P Ulivi, GL Frassineti, C Milandri, ...
Clinical cancer research 9 (2), 900-905, 2003
572003
Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer
C Arienti, M Zanoni, S Pignatta, A Del Rio, S Carloni, M Tebaldi, G Tedaldi, ...
Oncotarget 7 (14), 18424, 2016
562016
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20